company background image
605199 logo

Hainan Huluwa Pharmaceutical Group SHSE:605199 Stock Report

Last Price

CN¥10.10

Market Cap

CN¥4.0b

7D

-0.8%

1Y

-33.2%

Updated

13 Jul, 2024

Data

Company Financials

Hainan Huluwa Pharmaceutical Group Co., Ltd.

SHSE:605199 Stock Report

Market Cap: CN¥4.0b

605199 Stock Overview

Hainan Huluwa Pharmaceutical Group Co., Ltd.

605199 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Hainan Huluwa Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hainan Huluwa Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥10.10
52 Week HighCN¥20.09
52 Week LowCN¥9.36
Beta0.61
11 Month Change-2.70%
3 Month Change-13.53%
1 Year Change-33.20%
33 Year Change-58.42%
5 Year Changen/a
Change since IPO35.21%

Recent News & Updates

Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Jun 07
Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

May 03
Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Jun 07
Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

May 03
Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

Shareholder Returns

605199CN PharmaceuticalsCN Market
7D-0.8%-0.6%1.2%
1Y-33.2%-15.3%-18.5%

Return vs Industry: 605199 underperformed the CN Pharmaceuticals industry which returned -15.3% over the past year.

Return vs Market: 605199 underperformed the CN Market which returned -18.5% over the past year.

Price Volatility

Is 605199's price volatile compared to industry and market?
605199 volatility
605199 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 605199 has not had significant price volatility in the past 3 months.

Volatility Over Time: 605199's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20052,468Jinping Liuwww.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products.

Hainan Huluwa Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Hainan Huluwa Pharmaceutical Group's earnings and revenue compare to its market cap?
605199 fundamental statistics
Market capCN¥4.04b
Earnings (TTM)CN¥94.97m
Revenue (TTM)CN¥1.81b

42.6x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
605199 income statement (TTM)
RevenueCN¥1.81b
Cost of RevenueCN¥890.16m
Gross ProfitCN¥918.17m
Other ExpensesCN¥823.20m
EarningsCN¥94.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)0.24
Gross Margin50.77%
Net Profit Margin5.25%
Debt/Equity Ratio108.0%

How did 605199 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.